熱門資訊> 正文
CareDx任命新首席财务官
2025-08-07 06:53
- CareDx (NASDAQ:CDNA) has appointed Nathan Smith as its new chief financial officer.
- Smith brings over 14 years of experience in molecular diagnostics, including senior roles at Myriad Genetics, Blackrock Neurotech, and WIN Brands.
- Source: Press release
More on CareDx
- CareDx: The Transplant Diagnostics Leader, But Challenges Will Increase On The Road Ahead
- CareDx Q2 2025 Earnings Preview
- CareDx Non-GAAP EPS of $0.10 misses by $0.02
- Seeking Alpha’s Quant Rating on CareDx
- Historical earnings data for CareDx
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
